Patent Assignment
Reel/Frame 072444/0525
Patent Security Agreement
Recorded: 2025-08-12
Pages: 29
Assignor
MANNKIND CORPORATION
Executed: 2025-08-06
Assignee
WILMINGTON TRUST, NATIONAL ASSOCIATION, AS COLLATERAL AGENT
1100 NORTH MARKET STREET, WILMINGTON, DELAWARE, 19890
Covered Properties
(212)
Inhaler
Patent:
824,015 →
Application:
29/553,303 →
Inhaler
Patent:
841,798 →
Application:
29/553,302 →
Inhaler
Patent:
824,016 →
Application:
29/553,305 →
Fluid Transfer Device
Patent:
667,946 →
Application:
29/361,753 →
Fluid Transfer Device
Patent:
687,948 →
Application:
29/428,565 →
Fluid Transfer Device
Patent:
706,415 →
Application:
29/458,166 →
Mouthpiece Cover
Patent:
802,116 →
Application:
29/579,594 →
Inhaler
Patent:
834,178 →
Application:
29/604,731 →
Medicament Delivery Device
Patent:
914,200 →
Application:
29/740,176 →
Mouthpiece Cover
Patent:
771,237 →
Application:
29/504,212 →
Blister Packaging
Patent:
643,308 →
Application:
29/375,859 →
Inhaler
Patent:
824,510 →
Application:
29/553,300 →
Medicament Delivery Device
Patent:
955,566 →
Application:
29/740,199 →
Medicament Delivery Device
Patent:
935,604 →
Application:
29/771,869 →
Cartridge for a Dry Powder Inhaler
Patent:
664,640 →
Application:
29/356,555 →
Inhaler
Patent:
851,748 →
Application:
29/625,323 →
Blister Packaging
Patent:
671,842 →
Application:
29/394,877 →
Inhaler Device
Patent:
674,893 →
Application:
29/404,464 →
Fluid Delivery Device
Patent:
1,011,511 →
Application:
29/772,317 →
Catalysis of Diketopiperazine Synthesis
Method of Drug Formulation Based on Increasing the Affinity of Crystalline Microparticle Surfaces for Active Agents
Method of Drug Formulation Based on Increasing the Affinity of Active Agents for Crystalline Microparticle Surfaces
Diketopiperazine Salts for Drug Delivery and Related Methods
Multi-Cartridge Fluid Delivery Device
Powder Transport Systems and Methods
Powder Dispensing and Sensing Apparatus and Methods
Method for Improving the Pharmaceutic Properties of Microparticles Comprising Diketopiperazine and an Active Agent
A Method of Treating Diabetes Type 2 by Metformin and an Ultrarapid Acting Insulin
Inhalation Apparatus
Catalysis of Diketopiperazine Synthesis
Powder Transport Systems and Methods
Diketopiperazine Microparticles with Defined Isomer Contents
Powder Dispensing and Sensing Apparatus and Methods
A Method of Controlling Glycemia by Ultrarapid Acting Insulin Without Adjusting an Insulin Dose for Meal Content
Diketopiperazine Salts for Drug Delivery and Related Methods
Substituted Diketopiperazine Analogs for Use as Drug Delivery Agents
Multi-Cartridge Fluid Delivery Device
Delivery of Active Agents
Method of Preventing Adverse Effects by Glp-1
Method of Drug Formulation of Compositions Comprising Crystalline Microparticle Surfaces
Dry Powder Inhaler and System for Drug Delivery
Dry powder drug delivery system
Reactor for Producing Pharmaceutical Particles in a Precipitation Process
Dry Powder Inhaler and System for Drug Delivery
Inhaler Adaptor for a Laser Diffraction Apparatus and Method for Measuring Particle Size Distribution
Method for Improving the Pharmaceutic Properties of Microparticles Comprising Diketopiperazine and an Active Agent
Apparatus, System and Method for Measuring Resistance of an Inhaler
Diketopiperazine Microparticles with Defined Specific Surface Areas
Apparatus and Method for Cryogranulating a Pharmaceutical Composition
A Method of Treating Diabetes Type 2 by Administering Ultrarapid Acting Insulin
Dry Powder Inhaler and System for Drug Delivery
Val (8) GLP-1 Composition and Method for Treating Functional Dyspepsia and/or Irritable Bowel Syndrome
Diketopiperazine Salts for Drug Delivery and Related Methods
Fluid Transfer Device
Method of Drug Formulation Based on Increasing the Affinity of Crystalline Microparticle Surfaces for Active Agents
Diketopiperazine Microparticles with Defined Specific Surface Areas
Fluid Delivery Device Needle Retraction Mechanisms, Cartridges and Expandable Hydraulic Fluid Seals
Catalysis of Diketopiperazine Synthesis
Diketopiperazine Microparticles with Defined Specific Surface Areas
Method and Composition for Treating Migraines
Powder Dispensing and Sensing Apparatus and Methods
Multi-Cartridge Fluid Delivery Device
Substituted Diketopiperazine Analogs for Use as Drug Delivery Agents
Apparatus, System and Method for Measuring Resistance of an Inhaler
Dry Powder Inhaler and System for Drug Delivery
Formation of N-Protected bis-3,6-(4-aminoalkyl)-2,5,diketopiperazine
Blister Package for Pharmaceutical Cartridges
Formation of N-Protected Bis-3,6-(4-Aminobutyl)-2,5-Diketopiperazine Through a Cyclic Alpha-N-Protected Amino Ester
Apparatus and Method for Simulating Inhalation Efforts
Laser Diffraction with Inhaler Enclosed in Positive Pressure Chamber.
Method of Drug Formulation Based on Increasing the Affinity of Active Agents for Crystalline Microparticle Surfaces
Hydraulically Actuated Pump for Long Duration Medicament Administration
Method of Drug Formulation Based on Increasing the Affinity of Active Agents for Crystalline Microparticle Surfaces
Fluid Delivery Device
Hydraulically Actuated Pump for Fluid Administration
Determining Percent Solids in Suspension Using Raman Spectroscopy
Formation of N-Protected 3,6-Bis-(4-Aminobutyl) -2, 5-Diketopiperazine Through a Cyclic Alpha-N-Protected Active Amino Ester Intermediate
Dry Powder Inhaler and System for Drug Delivery
Methods for the Synthesis of Activated Ethylfumarates and Their Use as Intermediates
Substituted Diketopiperazine Analogs for Use as Drug Delivery Agents
Powder Dispenser Modules and Powder Dispenser Assemblies
Methods and Compositions for Treating Pain
Method for Improving the Pharmaceutic Properties of Microparticles Comprising Diketopiperazine and an Active Agent
Diketopiperazine salts for drug delivery and related methods
Method of Drug Formulation Based on Increasing the Affinity of Crystalline Microparticle Surfaces for Active Agents
Dry Powder Inhaler and System for Drug Delivery
Catalysis of Diketopiperazine Synthesis
Laser Diffraction with Inhaler Enclosed in Positive Pressure Chamber
Dry Powder Drug Delivery System and Methods
High Capacity Diketopiperazine Microparticles and Methods
Interactive Apparatus and Method for Real-Time Profiling of Inhalation Efforts
Fluid Transfer Device
Determining Percent Solids in Suspension Using Raman Spectroscopy
Dry Powder Drug Delivery System
Formation of N-Protected bis-3,6-(4-aminoalkyl)-2,5,diketopiperazine
Increasing Drug Affinity for Crystalline Microparticle Surfaces
Dry Powder Inhaler and System for Drug Delivery
Dry Powder Inhaler and System for Drug Delivery
Apparatus and Method for Cryogranulating a Pharmaceutical Composition
Use of Ultrarapid Acting Insulin
Methods and Compositions for Treating Pain
Determining Percent Solids in Suspension Using Raman Spectroscopy
Diketopiperazine Microparticles with Defined Specific Surface Areas
Substituted Diketopiperazine Analogs for Use as Drug Delivery Agents
Dry Powder Drug Delivery System and Methods
Diketopiperazine salts for drug delivery and related methods
Multi-Cartridge Fluid Delivery Device
Apparatus and Method for Simulating Inhalation Efforts
Method of Drug Formulation Based on Increasing the Affinity of Crystalline Microparticle Surfaces for Active Agents
Powder Dispensing and Sensing Apparatus and Methods
Fluid Delivery Device Needle Retraction Mechanisms, Cartridges and Expandable Hydraulic Fluid Seals
Catalysis of Diketopiperazine Synthesis
Dry Powder Drug Delivery System and Methods
Moving Basal Engine For A Fluid Delivery Device
Fluid Transfer Device
Heat-Stable Dry Powder Pharmaceutical Compositions and Methods
Use of Ultrarapid Acting Insulin
Formation of N-Protected Bis-3,6- (4-Aminobutyl) -2, 5-Diketopiperazine Through a Cyclic Alpha-N-Protected Amino Ester
Fluid Delivery Device
Apparatus, System and Method for Measuring Resistance of an Inhaler
Use of Ultrarapid Acting Insulin
Apparatus and Method for Cryogranulating a Pharmaceutical Composition
Methods for the synthesis of activated ethylfumarates and their use as intermediates
Catalysis of Diketopiperazine Synthesis
Method for Improving the Pharmaceutic Properties of Microparticles Comprising Diketopiperazine and an Active Agent
Diketopiperazine Salts for Drug Delivery and Related Methods
High Capacity Diketopiperazine Microparticles and Methods
Method of Drug Formulation
Inhalable Vaccine Compositions and Methods
Substituted Diketopiperazine Analogs for Use as Drug Delivery Agents
Formation of N-Protected 3,6-bis-(4-aminoalkyl)-2,5,diketopiperazine
Dry Powder Inhaler and System for Drug Delivery
Methods and Compositions for Reducing Opioid Side Effects
Use of Ultrarapid Acting Insulin
Cartridge Insertion Mechanism for a Fluid Delivery Device
Dry Powder Drug Delivery System
Method of Drug Formulation Based on Increasing the Affinity of Crystalline Microparticle Surfaces for Active Agents
Method for Improving the Pharmaceutic Properties of Microparticles Comprising Diketopiperazine and an Active Agent
High Capacity Diketopiperazine Microparticles and Methods
Fluid Delivery Device Needle Retraction Mechanisms, Cartridges and Expandable Hydraulic Fluid Seals
Heat-Stable Dry Powder Pharmaceutical Compositions and Methods
Microcrystalline Diketopiperazine Compositions and Methods
Multi-Cartridge Fluid Delivery Device
Apparatus and Method for Cryogranulating a Pharmaceutical Composition
Mouthpiece Cover for an Inhaler
Formation of N-Protected 3,6-Bis-(4-Aminobutyl)-2,5-Diketopiperazine Through a Cyclic Alpha-N-Protected Amino Ester Intermediate
Diketopiperazine Salts for Drug Delivery and Related Methods
A Fluid Delivery Device Having An Insertable Prefilled Cartridge
High Capacity Diketopiperazine Microparticles and Methods
Catalysis of Diketopiperazine Synthesis
Powder Dispensing and Sensing Apparatus and Methods for Simultaneous Filling of Cartridges
Blister Package for Pharmaceutical Cartridges
Formation of N-Protected 3,6-Bis-(4-Aminoalkyl)-2,5,Diketopiperazine
Interactive Apparatus and Method for Real-Time Profiling of Inhalation Efforts
Dry Powder Drug Delivery System and Methods
Microcrystalline Diketopiperazine Compositions and Methods
Dry Powder Inhaler and System for Drug Delivery
Moving Basal Engine For A Fluid Delivery Device
Diketopiperazine Microparticles with Defined Specific Surface Areas
Use of Ultrarapid Acting Insulin
Method of Treating Diabetes Type 2 by Administering Ultrarapid Acting Insulin
Methods for the synthesis of activated ethylfumarates and their use as intermediates
Formation of N-Protected 3,6-Bis-(4-Aminobutyl)-2,5-Diketopiperazine Through a Cyclic Alpha-N-Protected Amino Ester
Diketopiperazine Salts for Drug Delivery and Related Methods
Fluid Delivery Device
Needle Control and Drug Mixing Systems for a Fluid Delivery Device
Heat-Stable Dry Powder Pharmaceutical Compositions and Methods
Method of Drug Formulation Based on Increasing the Affinity of Crystalline Microparticle Surfaces for Active Agents
Use of Ultrarapid Acting Insulin
Apparatus and Method for Cryogranulating a Pharmaceutical Composition
Method of Drug Formulation Based on Increasing the Affinity of Active Agents for Crystalline Microparticle Surfaces
Reactor for Producing Pharmaceutical Particles in a Precipitation Process
Composition and Method for Reducing Hypoglycemia Events in Diabetes Treatment
Dry Powder Inhaler and System for Drug Delivery
Microcrystalline Diketopiperazine Compositions and Methods
Dry Powder Inhaler and System for Drug Delivery
Time Delay Mechanism for a Hydraulic Drug Delivery Device
Catalysis of Diketopiperazine Synthesis
Formation of N-Protected 3,6-Bis-(4-Aminobutyl)-2,5-Diketopiperazine Through a Cyclic Alpha-N-Protected Amino Ester
High Capacity Diketopiperazine Microparticles and Methods
Formation of N-Protected 3,6-bis-(4-aminoalkyl)-2,5,diketopiperazine
Insufflation Apparatus and Methods
Apparatus, System and Method for Detecting and Monitoring Inhalations
Methods for the synthesis of activated ethylfumarates and their use as intermediates
Use of Ultrarapid Acting Insulin
Diketopiperazine Microparticles with Defined Specific Surface Areas
Dry Powder Drug Delivery System and Methods
Fluid Delivery Device Having an Insertable Prefilled Cartridge
Moving Basal Engine For A Fluid Delivery Device
Communication Accessory for a Drug Delivery Device
Time Delay Mechanism for a Hydraulic Drug Delivery Device
Prodrugs of Treprostinil
Compositions of Clofazimine, Combinations Comprising Them, Processes for Their Preparation, Uses and Methods Comprising Them
Interactive Apparatus and Method for Real-Time Profiling of Inhalation Efforts
Apparatus and Method for Cryogranulating a Pharmaceutical Composition
Diketopiperazine salts for drug delivery and related methods
Use of Ultrarapid Acting Insulin
Cartridge Insertion Mechanism for a Fluid Delivery Device
A Method of Treating Hypoglycemia Events in Diabetes Treatment
Method of Treating Diabetes Type 2 by Administering Ultrarapid Acting Insulin
Dry Powder Inhaler and System for Drug Delivery
Adapter for a Fluid Transfer Device
Formation of N-Protected 3,6-Bis-(4-Aminobutyl)-2,5-Diketopiperazine Through a Cyclic Alpha-N-Protected Amino Ester
Dry Powder Drug Delivery System and Methods
Blister Package for Pharmaceutical Cartridges
Fluid Delivery Device Having an Insertable Prefilled Cartridge
Methods for the Synthesis of Activated Ethylfumarates and Their Use as Intermediates
Dry Powder Inhaler and System for Drug Delivery
Multi-Cartridge Fluid Delivery Device
Use of Ultrarapid Acting Insulin
Prodrugs of Treprostinil
Method and Composition for Treating Obesity
Related Assignments
(25)
Other recorded transfers of the patents in this record — the chain of ownership.
Assignment of Assignor's Interest
Nov 4, 2005
From: STEVENSON, JOHN J.; MOYE-SHERMAN, DESTARDI
To: MANNKIND CORPORATION
Reel/Frame 017177/0708 →
Assignment of Assignor's Interest
Nov 4, 2005
From: LEONE-BAY, ANDREA; MOYE-SHERMAN, DESTARDI; WILSON, BRYAN R.
To: MANNKIND CORPORATION
Reel/Frame 017197/0533 →
Assignment of Assignor's Interest
Nov 14, 2006
From: HOKENSON, MARK; OBERG, KEITH A.
To: MANNKIND CORPORATION
Reel/Frame 018518/0038 →
Assignment of Assignor's Interest
Nov 14, 2006
From: OBERG, KEITH A.
To: MANNKIND CORPORATION
Reel/Frame 018517/0426 →
Assignment of Assignor's Interest
Jun 21, 2010
From: GONNELLI, ROBERT R.; LEVESQUE, STEVEN F.; STANDLEY, ROBERT L.; CAPOLONGO, MARIO T.
To: VALERITAS, INC.
Reel/Frame 024566/0260 →
Assignment of Assignor's Interest
Sep 29, 2010
From: SMUTNEY, CHAD C.; POLIDORO, JOHN M.; ADAMO, BENOIT; KINSEY, P. SPENCER
To: MANNKIND CORPORATION
Reel/Frame 025059/0633 →
Assignment of Assignor's Interest
Oct 1, 2010
From: BERGEY, MICHAEL S.
To: MANNKIND CORPORATION
Reel/Frame 025079/0156 →
Assignment of Assignor's Interest
Nov 9, 2011
From: KINSEY, P. SPENCER; ADAMO, BENOIT
To: MANNKIND CORPORATION
Reel/Frame 027199/0600 →
Assignment of Assignor's Interest
Nov 29, 2011
From: BERGEY, MICHAEL S.
To: MANNKIND CORPORATION
Reel/Frame 027295/0024 →
Assignment of Assignor's Interest
Aug 1, 2012
From: LEVESQUE, STEVEN F.; GONNELLI, ROBERT R.; STANDLEY, ROBERT L.; CAPOLONGO, MARIO T.
To: VALERITAS, INC.
Reel/Frame 028693/0547 →
Short-Form Patent Security Agreement
May 28, 2013
From: VALERITAS, INC.
To: CAPITAL ROYALTY PARTNERS II L.P.; CAPITAL ROYALTY PARTNERS II - PARALLEL FUND "A" L.P.; PARALLEL INVESTMENT OPPORTUNITIES PARTNERS II L.P.
Reel/Frame 030497/0800 →
Assignment of Assignor's Interest
Jun 17, 2013
From: GONNELLI, ROBERT R.; LEVESQUE, STEVEN F.; STANDLEY, ROBERT L.; CAPOLONGO, MARIO T.
To: VALERITAS, INC.
Reel/Frame 030626/0817 →
Security Agreement
Jul 3, 2013
From: MANNKIND CORPORATION
To: DEERFIELD PRIVATE DESIGN FUND II, L.P.; DEERFIELD PRIVATE DESIGN INTERNATIONAL II, L.P.; HORIZON SANTE FLML SARL
Reel/Frame 030740/0123 →
Patent Security Agreement
Sep 26, 2014
From: MANNKIND CORPORATION
To: AVENTISUB LLC
Reel/Frame 033831/0110 →
Assignment of Assignor's Interest
Jan 2, 2015
From: SMUTNEY, CHAD C.; KINSEY, P. SPENCER
To: MANNKIND CORPORATION
Reel/Frame 034612/0036 →
Assignment of Assignor's Interest
Mar 2, 2016
From: KINSEY, P. SPENCER; LAURENZI, BRENDAN; ADAMO, BENOIT
To: MANNKIND CORPORATION
Reel/Frame 037875/0302 →
Assignment of Assignor's Interest
Mar 2, 2016
From: KINSEY, P. SPENCER; LAURENZI, BRENDAN; SMUTNEY, CHAD C.; ADAMO, BENOIT
To: MANNKIND CORPORATION
Reel/Frame 037875/0405 →
Assignment of Assignor's Interest
Mar 2, 2016
From: KINSEY, P. SPENCER; LAURENZI, BRENDAN; ADAMO, BENOIT
To: MANNKIND CORPORATION
Reel/Frame 037875/0456 →
Assignment of Assignor's Interest
Mar 2, 2016
From: ADAMO, BENOIT; KINSEY, P. SPENCER; LAURENZI, BRENDAN
To: MANNKIND CORPORATION
Reel/Frame 037875/0247 →
Release of Security Interest
Nov 10, 2016
From: AVENTISUB LLC
To: MANNKIND CORPORATION
Reel/Frame 040588/0008 →
Assignment of Assignor's Interest
Nov 10, 2016
From: SMUTNEY, CHAD C.; KINSEY, P. SPENCER
To: MANNKIND CORPORATION
Reel/Frame 040279/0966 →
Assignment of Assignor's Interest
Jul 18, 2017
From: KINSEY, P. SPENCER; LAURENZI, BRENDAN; ADAMO, BENOIT; SMUTNEY, CHAD C.
To: MANNKIND CORPORATION
Reel/Frame 043030/0387 →
Assignment of Assignor's Interest
Feb 7, 2018
From: KINSEY, P. SPENCER; SMUTNEY, CHAD C.
To: MANNKIND CORPORATION
Reel/Frame 044860/0319 →
Security Interest
Aug 13, 2019
From: MANNKIND CORPORATION; MANNKIND LLC
To: MIDCAP FINANCIAL TRUST, AS AGENT
Reel/Frame 050044/0181 →
Release of Security Interest
Aug 13, 2019
From: DEERFIELD PRIVATE DESIGN FUND II, L.P.; DEERFIELD PRIVATE DESIGN INTERNATIONAL II, L.P.; HORIZON SANTE FLML SARL
To: MANNKIND CORPORATION
Reel/Frame 050044/0138 →